The vomeronasal 1 receptor 237 (V1R237) is a protein that belongs to the vomeronasal 1 receptor (V1R) family, which itself is part of the larger G protein-coupled receptor (GPCR) superfamily. GPCRs are a diverse group of membrane proteins that play critical roles in transmitting signals from the outside of the cell to the inside. V1R receptors are specifically expressed in the vomeronasal organ (VNO), an olfactory chemosensory organ involved in the detection of pheromones and other chemical signals that are crucial for a variety of social and reproductive behaviors in certain vertebrates, especially rodents.
The VNO is situated at the base of the nasal septum and is key in detecting pheromones that influence innate behaviors such as mating, aggression, and territoriality. The V1R237, like other members of its receptor family, is thought to bind to specific chemical ligands - typically species-specific pheromones - which leads to receptor activation. Upon activation, these receptors couple with G proteins that initiate a cascade of intracellular signaling events. These events result in the generation of an electrical signal which is conveyed to the accessory olfactory bulb in the brain, where it is then processed and can lead to behavioral responses.The detailed physiological and behavioral functions of V1R237 are a subject of ongoing research, and much of what is understood about the receptor comes from studies in model organisms like mice. V1R receptors are known to have a vast repertoire with significant variation, which allows for the detection of a wide range of chemical signals. The specificity and sensitivity of V1R237 and its related receptors underscore the complexity of chemical communication and its evolutionary importance in the context of social interactions and species survival.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Andrographolide | 5508-58-7 | sc-205594 sc-205594A | 50 mg 100 mg | $15.00 $40.00 | 7 | |
Andrographolide may inhibit V1R237 expression by modulating transcription factors or signaling cascades. | ||||||
Celastrol, Celastrus scandens | 34157-83-0 | sc-202534 | 10 mg | $158.00 | 6 | |
Celastrol has been shown to inhibit gene expression by interfering with transcription factors or signaling cascades. | ||||||
Gossypol | 303-45-7 | sc-200501 sc-200501A | 25 mg 100 mg | $116.00 $230.00 | 12 | |
Gossypol can inhibit gene expression by disrupting transcription factors or modulating signaling pathways. | ||||||
Tanshinone IIA | 568-72-9 | sc-200932 sc-200932A | 5 mg 25 mg | $88.00 $316.00 | 22 | |
Tanshinone IIA may inhibit V1R237 expression by affecting transcriptional machinery or modulating signaling pathways. | ||||||
Ellagic Acid, Dihydrate | 476-66-4 | sc-202598 sc-202598A sc-202598B sc-202598C | 500 mg 5 g 25 g 100 g | $58.00 $95.00 $245.00 $727.00 | 8 | |
Ellagic acid can modulate gene expression by affecting transcription factors or signaling cascades. | ||||||
Withaferin A | 5119-48-2 | sc-200381 sc-200381A sc-200381B sc-200381C | 1 mg 10 mg 100 mg 1 g | $130.00 $583.00 $4172.00 $20506.00 | 20 | |
Withaferin A may inhibit V1R237 expression by interfering with transcriptional regulators or signaling cascades. | ||||||
Wogonin, S. baicalensis | 632-85-9 | sc-203313 | 10 mg | $200.00 | 8 | |
Wogonin may inhibit V1R237 expression by modulating transcriptional regulators or signaling cascades. | ||||||
Betulinic Acid | 472-15-1 | sc-200132 sc-200132A | 25 mg 100 mg | $117.00 $344.00 | 3 | |
Betulinic acid can modulate gene expression through interactions with transcriptional regulators or signaling pathways. | ||||||
Artemisinin | 63968-64-9 | sc-202960 sc-202960A | 100 mg 1 g | $45.00 $252.00 | 1 | |
Artemisinin can inhibit gene expression through interactions with transcription factors or signaling pathways. | ||||||
Xanthohumol from hop (Humulus lupulus) | 6754-58-1 | sc-301982 | 5 mg | $361.00 | 1 | |
Xanthohumol can modulate gene expression through interactions with transcriptional regulators or signaling pathways. | ||||||